Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $98,600 | 30 | 45.8% |
| Unspecified | $86,161 | 2 | 40.0% |
| Travel and Lodging | $25,036 | 47 | 11.6% |
| Food and Beverage | $3,444 | 68 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,990 | 1 | 0.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cepheid | $86,161 | 2 | $0 (2017) |
| Merck Sharp & Dohme LLC | $50,782 | 55 | $0 (2024) |
| ViiV Healthcare Company | $32,926 | 14 | $0 (2024) |
| Gilead Sciences, Inc. | $32,898 | 54 | $0 (2024) |
| Roche Diagnostics Corporation | $6,579 | 3 | $0 (2024) |
| Theratechnologies Inc. | $3,000 | 1 | $0 (2021) |
| ModernaTX, Inc. | $1,660 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,093 | 13 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $116.82 | 1 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $16.67 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41,160 | 28 | ViiV Healthcare Company ($24,044) |
| 2023 | $5,389 | 17 | Gilead Sciences, Inc. ($2,428) |
| 2022 | $20,863 | 13 | Merck Sharp & Dohme LLC ($15,419) |
| 2021 | $19,602 | 10 | ViiV Healthcare Company ($8,849) |
| 2020 | $1,077 | 4 | Gilead Sciences, Inc. ($1,020) |
| 2019 | $21,865 | 34 | Gilead Sciences, Inc. ($13,629) |
| 2018 | $18,964 | 38 | Merck Sharp & Dohme Corporation ($11,815) |
| 2017 | $86,311 | 4 | Cepheid ($86,161) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,092.50 | General |
| 07/22/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $4,185.00 | General |
| 07/22/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| 06/05/2024 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $9,100.00 | General |
| 06/05/2024 | ViiV Healthcare Company | — | Travel and Lodging | Cash or cash equivalent | $565.44 | General |
| 06/04/2024 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $9,432.30 | General |
| 06/04/2024 | Roche Diagnostics Corporation | — | Consulting Fee | Cash or cash equivalent | $3,626.00 | General |
| Category: None | ||||||
| 06/04/2024 | ViiV Healthcare Company | — | Travel and Lodging | Cash or cash equivalent | $459.34 | General |
| 06/04/2024 | ViiV Healthcare Company | — | Travel and Lodging | Cash or cash equivalent | $126.75 | General |
| 05/09/2024 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $4,029.33 | General |
| 05/09/2024 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $178.75 | General |
| 05/09/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $78.55 | General |
| 05/09/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $73.39 | General |
| 04/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $424.64 | General |
| 04/12/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $265.07 | General |
| 04/12/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $27.37 | General |
| 04/12/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $26.64 | General |
| 03/19/2024 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,120.00 | General |
| 03/07/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $83.19 | General |
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $49.99 | General |
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $49.99 | General |
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $46.36 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GeneXpert | Cepheid | $28,766 | 1 |
About Dr. Kenneth Mayer, M.D
Dr. Kenneth Mayer, M.D is a Infectious Disease healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861439812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Mayer, M.D has received a total of $215,232 in payments from pharmaceutical and medical device companies, with $41,160 received in 2024. These payments were reported across 148 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($98,600).
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location Providence, RI
- Active Since 05/31/2006
- Last Updated 11/14/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1861439812
Products in Payments
- GeneXpert (Medical Supply) $86,161
- DELSTRIGO (Drug) $16,600
- Biktarvy (Drug) $2,810
- Truvada (Drug) $1,990
- TRELEGY ELLIPTA (Drug) $146.94
- PREZCOBIX (Drug) $116.82
- cobas HBV/HCV/HIV-1 Control Kit (Device) $53.33
- TIVICAY (Drug) $32.71
- SHINGRIX (Biological) $25.81
- AJOVY (Biological) $16.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Providence
Angela Caliendo, M.d., Ph.d, M.D., PH.D
Infectious Disease — Payments: $74,183
Timothy Flanigan, Md, MD
Infectious Disease — Payments: $57,834
Maria Mileno, Md, MD
Infectious Disease — Payments: $9,583
Rami Kantor, M.d, M.D
Infectious Disease — Payments: $8,643
Susan Cu Uvin, Md, MD
Infectious Disease — Payments: $7,364
Richa Tandon, M.d, M.D
Infectious Disease — Payments: $4,467